| Issue Type | Login |
|---|---|
| Country | Denmark |
| Industry | Login |
| Region | Login |
| Maturity Date | 2029-06-11 |
| Par Value | 100000 |
| Callable | Login |
| Next Call Date | Login |
| Call Type | Login |
| Call Price (%) | Login |
| Series | Login |
| Class | Login |
| Maturity Structure | Login |
| Amount Outstanding (mil) | 180.00 |
| Coupon | 0.575 |
|---|---|
| Coupon Type | Login |
| Coupon Frequency | Login |
| First Coupon Date | Login |
| Last Coupon Date | Login |
| Sinking Fund | Login |
|---|---|
| Security | Login |
| Subordination | Login |
| Debt Type | Login |
| Issue Date | Login |
|---|---|
| Dated Date | Login |
| Issue Size (mil) | 180.000 |
| Min. Piece | Login |
| Min. Increment | Login |
This Novo Nordisk corporate bond has a 0.57% fixed rate coupon paid on a Login basis. It was issued on MAR 12, 2000 with an issue size of 180.00 million CHF and matures on June 11, 2029 with a last coupon date of FEB 28, 2020. |
Novo Nordisk is a global healthcare company founded in 1923 and headquartered in Bagsværd, Denmark. The company specializes in diabetes care and biopharmaceuticals, offering a range of products that include insulin, GLP-1 receptor agonists, and hemophilia treatments.